CAS 202402-01-5

Formel: C13H16F3NO2

InChl: InChI=1S/C13H16F3NO2/c1-19-8-2-3-12(18)17-9-10-4-6-11(7-5-10)13(14,15)16/h4-7H,2-3,8-9H2,1H3,(H,17,18)

InChI Key: QLZOWJNFLXSDSH-UHFFFAOYSA-N

SMILES: COCCCC(=O)NCC1=CC=C(C=C1)C(F)(F)F

GET73

CAS: 202402-01-5

GET73 (Gamma hydroxybutyric acid analogue) is an negative allosteric modulator of mGluR5.

Formel: C₁₃H₁₆F₃NO₂

Reinheit: 99.54%

Farbe und Form: Solid

Molekulargewicht: 275.2668

Ref: TM-T11393

GET73

CAS: 202402-01-5

GET73

Formel: C₁₃H₁₆F₃NO₂

Reinheit: 99.5%

Molekulargewicht: 275.27

Ref: 54-BUP09278

4-Methoxy-N-(4-(trifluoromethyl)benzyl)butanamide

CAS: 202402-01-5

Formel: C₁₃H₁₆F₃NO₂

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 275.2668

Ref: IN-DA01FSQG

GET73

CAS: 202402-01-5

4-Methoxy-N-(4-(trifluoromethyl)benzyl)butanamide

Formel: C₁₃H₁₆F₃NO₂

Reinheit: 99%

Molekulargewicht: 275.27

Ref: IN-DG768073

Butanamide, 4-methoxy-N-[[4-(trifluoromethyl)phenyl]methyl]-

CAS: 202402-01-5

Reinheit: 99%

Molekulargewicht: 275.2709961

Ref: 10-F864262

4-Methoxy-N-((4-(trifluoromethyl)phenyl)methyl)-butanamide

CAS: 202402-01-5

4-Methoxy-N-((4-(trifluoromethyl)phenyl)methyl)-butanamide is a metabotropic glutamate receptor (mGluR) agonist. It has been shown to produce concentration-response curves in functional assays with glutamate that show an amide concentration-response curve, as well as an allosteric modulator profile. 4-Methoxy-N-((4-(trifluoromethyl)phenyl)methyl)-butanamide has also been shown to have anxiolytic properties and may be useful for treating cognitive dysfunction related to schizophrenia, Alzheimer's disease, Parkinson's disease and Huntington's disease.

Formel: C₁₃H₁₆F₃NO₂

Reinheit: Min. 95%

Molekulargewicht: 275.27 g/mol

Ref: 3D-CIA40201